| International Nonproprietary Names (INN) |
Recommended INN List No. 87 | WHO Drug Information,2022,36,1 | 查看 |
| Consultation Documents |
1.14.1 Chromatography | WHO Drug Information,2022,36,1 | 查看 |
| Consultation Documents |
Molnupiravir | WHO Drug Information,2022,36,1 | 查看 |
| Consultation Documents |
Molnupiravir capsules | WHO Drug Information,2022,36,1 | 查看 |
| Consultation Documents |
TENOFOVIR DISOPROXIL FUMARATE | WHO Drug Information,2022,36,1 | 查看 |
| International Nonproprietary N |
Proposed INN List No. 126 | WHO Drug Information,2021,35,4 | 查看 |
| Consultation Documents |
Isoniazid (isoniazidum) | WHO Drug Information,2021,35,4 | 查看 |
| Consultation Documents |
Sodium laurilsulfate (natrii laurilsulfas) | WHO Drug Information,2021,35,4 | 查看 |
| Consultation Documents |
Hydroxypropylcellulose, low-substituted (hydroxypropylcellulosum substitutum humile) | WHO Drug Information,2021,35,4 | 查看 |
| Consultation Documents |
Sodium Starch Glycolate (natrii amyla glycolas) | WHO Drug Information,2021,35,4 | 查看 |
| Pharmaceutical News |
Prescribing with International Nonproprietary Names – Facilitating Communication and Improving Access to
Medical Substances by Increasing the Use of Non-originator Pharmaceutical Products | WHO Drug Information,2021,35,4 | 查看 |
| Pharmaceutical News |
International Nonproprietary Names: Translating the Science of Nomenclature into a Global Language for Education
and Practice | WHO Drug Information,2021,35,4 | 查看 |
| Regulatory News |
Extraordinary (Virtual) International Conference of Drug Regulatory Authorities (ICDRA) - Recommendations | WHO Drug Information,2021,35,4 | 查看 |
| International Nonproprietary N |
Recommended INN List No. 86 | WHO Drug Information,2021,35,3 | 查看 |
| Consultation Documents |
Benzathine benzylpenicillin for injection (benzathini benzylpenicillini ad injectionem) | WHO Drug Information,2021,35,3 | 查看 |
| Consultation Documents |
Benzathine benzylpenicillin tetrahydrate (benzathini benzylpenicillinum tetrahydricum) | WHO Drug Information,2021,35,3 | 查看 |
| Consultation Documents |
Dolutegravir Dispersible Tablets (dolutegraviri compressi dispersibili) | WHO Drug Information,2021,35,3 | 查看 |
| Consultation Documents |
WHO Good Manufacturing Practices for Investigational Products | WHO Drug Information,2021,35,3 | 查看 |
| Consultation Documents |
WHO Good Practices for Research and Development Facilities of Pharmaceutical Products | WHO Drug Information,2021,35,3 | 查看 |
| Consultation Documents |
IAEA/WHO Guideline on Good Manufacturing Practices for Investigational Radiopharmaceutical Products | WHO Drug Information,2021,35,3 | 查看 |
